USP Zdrowie sp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2010-02-01
Share capital
25,610,250.00 PLN
Activity description

USP Zdrowie has been a leader in Poland’s over-the-counter (OTC) medicines and healthcare products market for more than 30 years. The company develops 40 health-related brands, including Ibuprom, Apap and Gripex, and employs 600 people.

Registered address
ul. Poleczki 35, 02-822 Warszawa, Poland
Branches
  • ul. Ryszarda Chomicza 13F, 55-080 Nowa Wieś Wrocławska
Phone
Social media
Electronic delivery address
AE:PL-72546-53316-EFBGT-15

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$8,149,085

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 24 days late). All were audited by a statutory auditor.

  • 202514/07/2026
  • 202411/07/2025
  • 202325/06/2024
  • 202210/07/2023
  • 202108/08/2022
  • 202027/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods18 / 1,136
Top 1.6%
Division · Wholesale trade68 / 20,037
Top <1%
City · Warszawa183 / 56,729
Top <1%
Voivodeship · Mazowieckie219 / 76,892
Top <1%
Country · Poland536 / 297,069
Top <1%

Results vs industry

Revenue
This companyUSD 377.15mMedianUSD 1.08mAverageUSD 22.54m
Net profit
This companyUSD 34.55mMedianUSD 39.26kAverageUSD 885.01k
Operating costs
This companyUSD 325.63mMedianUSD 963.92kAverageUSD 21.21m
Assets
This companyUSD 299.66mMedianUSD 610.11kAverageUSD 11.92m

Offer

Websites

Trademarks

The company holds 32 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 1997.

MarkNumberClassesStatusProtected until
USP Zdrowie Z.5010673, 5, 10, 35, 39, 40, 41, 42, 44Protected Jun 12, 2029
USP Zdrowie Z.5010573, 5, 10, 35, 39, 40, 41, 42, 44Protected Jun 12, 2029
Centrum Stworzone dla Zdrowia Z.5010563, 5, 10, 35, 39, 40, 41, 42, 44Protected Jun 12, 2029
USP Zdrowie (word)Z.4746243, 5, 10Protected Jul 25, 2027
US Pharmacia (word)Z.4746253, 5, 10Protected Jul 25, 2027
MarkProtected until
USP Zdrowie Jun 12, 2029
USP Zdrowie Jun 12, 2029
Centrum Stworzone dla Zdrowia Jun 12, 2029
USP Zdrowie (word)Jul 25, 2027
US Pharmacia (word)Jul 25, 2027

Job offers

The company has its own careers page: uspzdrowie.pl/kariera.

Authorized Representatives

Marcin Andrzej Szałapski age 56 – Vice President of the Management Board
Anna Czyż age 46 – Attorney-in-fact (joint)
Małgorzata Brzozowska-Bejgier age 50 – Attorney-in-fact (joint)
Robert Jurgawka age 59 – President of the Management Board
Krzysztof Nowakowski age 53 – Attorney-in-fact (joint)

Manner of representation

Two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy.

Supervisory board

Francis Patrick Ostronic – Supervisory Board Member
Kazimierz Janusz Napiórkowski age 56 – Supervisory Board Member
Katarzyna Kuśmierz age 70 – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
Medvic S.a.r.l.
512,205$6,917,949.76100%

Beneficial owners

Person

Subsidiaries

NameStake
Healthily sp. z o.o.
100%
Selfish 3 sp. z o.o.
24.9667%

Bank accounts

Registered as a VAT taxpayer on 2010-08-17.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 437.5K

MSiG notices

Publication dateEvent
Feb 12, 2018Call to creditors
Mar 27, 2012Call to creditors
Jan 19, 2011Merger registered
Sep 9, 2010Merger registered

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Adamed Pharma S.A.
Bausch Health Poland sp. z o.o.
Aflofarm Farmacja Polska sp. z o.o.
Opella Healthcare Poland sp. z o.o.
Biofarm sp. z o.o.
Zentiva Polska sp. z o.o.
Angelini Pharma Polska sp. z o.o.
Farmak International sp. z o.o.
Synoptis Pharma sp. z o.o.
SUN-Farm sp. z o.o.

Change history

DateEvent
2025-03-11Address change
2018-05-29Share capital reduction
2017-01-26Share capital increase
2015-05-29PKD change
2012-07-20Share capital reduction

FAQ

Last updated: 2026-10-07